According to Chio et al., combined targeting inhibition of Akt signaling and synthesis of glutathione could mimic Nrf2 ablation and effectively inhibit the survival of pancreatic ductal adenocarcinoma cells (PDACs) in vitro and in vivo [58]. This evidence concerns the gene AKT1 and pancreatic ductal adenocarcinoma.